Niro has developed a completely new series of spray dryers dedicated to the pharmaceutical industry manufacturing. The new dryers, named PHARMASD™ (PSD) have been designed using standard modules that incorporate all the required features necessary for cGMP production in the environment of a pharmaceutical plant.

NEW Innovations

Tomorrow's technology today

  • We have pioneered Pharma Spray Drying to provide unprecedented control of particle form and release profile for drug development, meeting the most demanding clinical needs.

Niro Pharmaceutical Spray Dryers

PharmaSD™ Spray Dryers
For 75 years, Niro has supplied drying plants for powders and particulates to the pharmaceutical industry. This includes small capacity spray dryers designed for R & D as well as industrial size plants for continuous production of pharmaceutical compounds under cGMP conditions ... Read more and download

Commercialising discovery with Niro spray drying
Many potential treatments sit stranded between basic research and prescription medicine due to issues such as insolubility, instability and delivery system. What’s more, this trend is gathering momentum as companies explore new routes to drug discovery, such as biotechnology research. Spray drying is a breakthrough technology that offers R & D staff a unique remedy to some of the formulation challenges facing the modern pharmaceutical business ... Read more and download

Niro Pharma Test Station for Spray Drying
The Niro Pharma Test Station is the world’s most advanced GMP test station for spray drying. It not only helps you refi ne products and processes under GMP conditions – with minimum development time and maximum security of outcome. It also enables you to limit your upfront investment in spray drying equipment until you’re sure you have a viable commercial product ... Read more and download

Technical article: Preparation of Granules by Spray Drying
An alternative process is to produce the active in a granular form during primary pharmaceutical production. These granules can then be blended with the excipients during secondary production. Most excipients used today can be purchased in a quality suitable for direct compression and an additional granulation/drying step then is not required. Alternatively active and excipients can be mixed together in the liquid phase and then be dried- as granules- together. To do so it is necessary to carry out the drying at the end of primary production in a FSD™ (Fluidised Spray Dryer) spray dryer ... Read more and download

Request Information
If you are interested in learning more about our Pharma Spray Dryers or any of our other GEA Pharma Systems products and/or services, please use this form to contact us.
Click here to request more information